| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bajaj Finserv Healthcare Fund Reg (G) |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.96 |
| Derivatives/Mutual Fund/ETF |
1.48 |
| Equity |
96.15 |
| Trep |
1.41 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
34.03% |
| Top 10 Holdings |
58.42% |
| Top 25 Holdings |
89.02% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
66.32 |
| Healthcare |
19.27 |
| Food Beverage & Tobacco |
2.82 |
| Cash |
2.37 |
| Chemicals |
2.17 |
| Consumer Durables |
2.03 |
| Debt MF |
1.48 |
| Retail |
1.18 |
| Miscellaneous |
1.04 |
| Technology |
1.0 |
| Electricals |
0.32 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
6.22 |
| PE Ratio |
52.04 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| DIVI LABORATORIES LTD |
8.40 |
| Apollo Hos Ent Ltd |
6.71 |
| Aurobindo Pharma Limited |
6.52 |
| Sun Pharmaceutical Industries Limited |
6.36 |
| Piramal Pharma Limited |
6.04 |
| Rubicon Research Limited |
6.02 |
| Torrent Pharmaceuticals Limited |
5.26 |
| Neuland Laboratories Limited |
4.59 |
| Emcure Pharmaceuticals Limited |
4.36 |
| Max Healthcare Institute Limited |
4.16 |
| Fortis Health Care Ltd |
3.25 |
| EQ -ZYDUS WELLNESS LTD. |
2.82 |
| IPCA Laboratories Limited |
2.43 |
| Vijaya Diagnostic Centre Limited |
2.36 |
| Senores Pharmaceuticals Limited |
2.29 |
| NAVIN FLUORINE INTERNATIONAL L |
2.17 |
| Laurus Labs Limited |
2.14 |
| Shaily Engineering Plastics Limited |
2.03 |
| SANOFI CONSUMER HEALTHCARE |
1.80 |
| Glenmark Pharmaceuticals Limited |
1.73 |
| GLAXO SMITHKLINE PHARMA |
1.65 |
| Dr Lal Path Labs Ltd |
1.64 |
| Bajaj Finserv Money Market Fund-Direct Plan-Growth |
1.48 |
| Clearing Corporation of India Ltd |
1.41 |
| Zydus Lifesciences Limited |
1.40 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
